Deans' stroke musings: FDA approves new multiple sclerosis treatment Aubagio

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, September 15, 2012

FDA approves new multiple sclerosis treatment Aubagio

Ok this is not directly related to stroke but a previous MS drug -

Dalfampridine -

showed promise in Stroke rehab, so ask our researchers if myelin repair is needed in our white matter after a stroke.
http://www.cbsnews.com/8301-504763_162-57512454-10391704/fda-approves-new-multiple-sclerosis-treatment-aubagio/
There are a few side effects so beware;
People taking Aubagio may experience diarrhea, abnormal liver tests, nausea, and hair loss, and there is a boxed warning that describes an increased risk of liver problems, including death, and a risk of birth defects. Tests on animals have shown that it may cause fetal harm, so patients cannot be pregnant while on the tablet.The FDA recommends that doctors perform a blood test to check liver function before putting patient on the medication.